Both in Pharmaceuticals
Actuate Therapeutics vs MetaVia
Over the past year ACTU returned −94.2% and MTVA returned −88.7%; their daily moves had a correlation of 0.07.
ACTU −94.2% MTVA −88.7%Growth of $1, one year, split-adjusted
| Metric | ACTU | MTVA |
|---|---|---|
| Price | $0.3699 | $1.34 |
| Market cap | $8.9M | $8.8M |
| Today | +5.69% | +6.35% |
| 1 month | −54.4% | −9.5% |
| 6 months | −87.6% | −4.3% |
| Year to date | −94.0% | −84.1% |
| 1 year | −94.5% | −87.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 161.7% | 65.1% |
| Short % of float | 19.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).